Cspc Baike (shandong) Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Cspc Baike (shandong) Biopharmaceutical Co., Ltd., explained in plain language.
-
New Weight-Loss drug SYH9017 enters human testing in china
Disease control Recruiting nowThis early-stage trial tests a new medicine called SYH9017 in 66 Chinese adults who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it after one or several doses. Participants receive either the drug or a placebo, and researchers …
Phase: PHASE1 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis study tests an experimental drug called CM326 in 230 adults with moderate to severe asthma. Participants will receive either the drug or a placebo for 52 weeks. The goal is to see if CM326 reduces severe asthma attacks and improves breathing. All participants will continue t…
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC